FindTrial
Sign In

Comparing LM and Centesimal potencies in treatment of post covid vaccination cases

Comparative study of LM potency with centesimal potency in management of post covid vaccination cases - an experimental uncontrolled clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107684
Enrollment
40
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T881- Other complications following immunization, not elsewhere classified

Interventions

Intervention1: Homoeopathic medicines in LM potency: Medicines selected based on individualized homoeopathic prescription. Prepared according to standard homoeopathic pharmacopoeia guidelines. Adminis

Sponsors

Dr Suchita Tupe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who have received covid vaccination will be included. 2. Patients of different socio- economic status will be included.

Exclusion criteria

Exclusion criteria: 1. Patient with critical, life-threatening conditions will be excluded. 2. Patient with gross pathological changes will be excluded.

Design outcomes

Primary

MeasureTime frame
Percentage Reduction in Symptom ScoreTimepoint: Outcome Assessment will be done only at pre study (baseline) and post study (at end of 3 months).Follow up visits will be conducted every month during this period.—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Anjali Shridharao Pangarkar

Sonajirao Kshirsagar Homoeopathic Medical College, Beed

suchitatupe55@gmail.com8379951227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026